Keyphrases
Pneumonia
100%
Population-based Cohort Study
100%
Dipeptidyl peptidase-4 (DPP-4)
100%
Antidiabetic Drugs
60%
Non-insulin
60%
Cumulative Dose
20%
Drug Users
20%
Type 2 Diabetes Mellitus Patients
20%
Daily Dose
20%
Comorbidity
10%
Immune System
10%
Confidence Interval
10%
Concomitant Use
10%
Cox Regression Analysis
10%
Infection Risk
10%
Population-based Study
10%
Type 2 Diabetes Prevention
10%
Type 2 Diabetes Mellitus (T2DM)
10%
Lifestyle Factors
10%
Elderly Patients
10%
Clinical Practice Research Datalink
10%
Indirect Evidence
10%
Primary Care Database
10%
Adjusted Hazard Ratio
10%
Medicine and Dentistry
Cohort Analysis
100%
Dipeptidyl Peptidase-4 Inhibitor
100%
Antidiabetic Agent
60%
Maturity Onset Diabetes of the Young
30%
Infection
10%
Hazard Ratio
10%
Immune System
10%
Proportional Hazards Model
10%
Primary Health Care
10%
Observational Study
10%
Elderly Patient
10%
Randomized Controlled Trial
10%
Comorbidity
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Dipeptidyl Peptidase IV Inhibitor
100%
Antidiabetic Agent
60%
Non Insulin Dependent Diabetes Mellitus
30%
Randomized Controlled Trial
10%
Observational Study
10%
Infection
10%
Comorbidity
10%